Annual Accounts Payable
$2.32 M
+$447.00 K+23.81%
31 December 2023
Summary:
Black Diamond Therapeutics annual accounts payable is currently $2.32 million, with the most recent change of +$447.00 thousand (+23.81%) on 31 December 2023. During the last 3 years, it has fallen by -$214.00 thousand (-8.43%). BDTX annual accounts payable is now -43.41% below its all-time high of $4.11 million, reached on 31 December 2021.BDTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.97 M
+$1.21 M+158.32%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly accounts payable is currently $1.97 million, with the most recent change of +$1.21 million (+158.32%) on 30 September 2024. Over the past year, it has increased by +$1.28 million (+184.01%). BDTX quarterly accounts payable is now -65.78% below its all-time high of $5.76 million, reached on 30 September 2022.BDTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | +184.0% |
| 3 y3 years | -8.4% | -59.4% |
| 5 y5 years | +458.6% | +39.7% |
BDTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.4% | +23.8% | -65.8% | +184.0% |
| 5 y | 5 years | -43.4% | +458.6% | -65.8% | +4280.0% |
| alltime | all time | -43.4% | +1429.0% | -65.8% | +4280.0% |
Black Diamond Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.97 M(+158.3%) |
| June 2024 | - | $763.00 K(-35.1%) |
| Mar 2024 | - | $1.18 M(-49.4%) |
| Dec 2023 | $2.32 M(+23.8%) | $2.32 M(+234.9%) |
| Sept 2023 | - | $694.00 K(-74.6%) |
| June 2023 | - | $2.74 M(-10.1%) |
| Mar 2023 | - | $3.05 M(+62.3%) |
| Dec 2022 | $1.88 M(-54.3%) | $1.88 M(-67.4%) |
| Sept 2022 | - | $5.76 M(+159.2%) |
| June 2022 | - | $2.22 M(+18.0%) |
| Mar 2022 | - | $1.88 M(-54.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $4.11 M(+61.8%) | $4.11 M(-15.5%) |
| Sept 2021 | - | $4.86 M(-3.4%) |
| June 2021 | - | $5.03 M(+9.0%) |
| Mar 2021 | - | $4.62 M(+81.9%) |
| Dec 2020 | $2.54 M(+29.2%) | $2.54 M(-13.4%) |
| Sept 2020 | - | $2.93 M(+6415.6%) |
| June 2020 | - | $45.00 K(-98.8%) |
| Mar 2020 | - | $3.80 M(+93.4%) |
| Dec 2019 | $1.96 M(+372.1%) | $1.96 M(+39.2%) |
| Sept 2019 | - | $1.41 M(+239.2%) |
| Dec 2018 | $416.00 K(+173.7%) | $416.00 K |
| Dec 2017 | $152.00 K | - |
FAQ
- What is Black Diamond Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual accounts payable year-on-year change?
- What is Black Diamond Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly accounts payable year-on-year change?
What is Black Diamond Therapeutics annual accounts payable?
The current annual accounts payable of BDTX is $2.32 M
What is the all time high annual accounts payable for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual accounts payable is $4.11 M
What is Black Diamond Therapeutics annual accounts payable year-on-year change?
Over the past year, BDTX annual accounts payable has changed by +$447.00 K (+23.81%)
What is Black Diamond Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BDTX is $1.97 M
What is the all time high quarterly accounts payable for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly accounts payable is $5.76 M
What is Black Diamond Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BDTX quarterly accounts payable has changed by +$1.28 M (+184.01%)